Long-term low-dose treatment with reserpine of cholesterol-fed rabbits reduces cholesterol in plasma, non-high density lipoproteins and arterial walls

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 1, 2002, Pages 67-79

  Shafi, Shahida ^a   Stepanova, Irina P ^a   Fitzsimmons, Colin ^a   Bowyer, David E ^a   Born, Gustav V R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arterial wall cholesterol; Atherosclerosis; Cholesterol fed rabbits; Lipoproteins; Reserpine

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; IODINE 125; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; RESERPINE; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FIBRINOGEN BLOOD LEVEL; HEART RATE VARIABILITY; HEMATOCRIT; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; CHOLESTEROL INTAKE; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; INFUSION PUMP; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMAL; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, DIETARY; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; INFUSION PUMPS, IMPLANTABLE; LIPOPROTEINS; MALE; RABBITS; RECEPTORS, LDL; RESERPINE; ANIMALS;

EID: 0035985481     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200207000-00009     Document Type: Article

References (55)

1. Haemostatic factors and prevalent coronary heart disease: The FINRISK haemostasis study
2. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analysis of prospective studies
3. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
4. Animal models for atherosclerosis
5. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation
6. Relation with fibrinogen and other haemostatic parameters
7. 2 synthesis
8. Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban
9. Antiinflammatory drugs in experimental atherosclerosis, part 5: Influence of cortisone acetate on short and long-term cholesterol fluxes in atherosclerotic aorta
10. The effects of propranolol on cholesterol-induced atheromatous lesions
11. Effects of propranolol on atherogenesis in the cholesterol-fed rabbit
12. Effect of metoprolol on diet-induced atherosclerosis in rabbits
13. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits
14. Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits
15. Preventive effects of competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits
16. Effects of doxazosin on atherosclerosis in cholesterol-fed rabbits
17. Effects of indapamide on atherosclerosis development in cholesterolfed rabbits
18. Effect of clentiazem on lipid profile, lipoprotein composition and aortic fatty streaks in cholesterol-fed rabbits
19. Recovery of noradrenaline levels after reserpine compared with the life-span of amine storage granules in rat and rabbit
20. The action of reserpine on the concentration of 5-hydroxytryptamine, epinephrine and norepinephrine in the venous blood of migraine patients
21. Effects of reserpine on the content and uptake of dopamine and noradrenaline in rabbit arteries
22. Sympatholytic action of intravenous amiodarone in the rat heart
23. Antihypertensive agents and the drug therapy of hypertension
24. Low dose reserpine/thiazide combination in first-line treatment of hypertension: Efficacy and safety compared to an ACE inhibitor
25. Effect of reserpine treatment on low density lipoproteins in arterial wall and internal organs of rats
26. The effects of reserpine and mecamylamine on experimental atheromatosis in the normotensive and hypertensive rats
27. Inhibition of cholesterol-induced vascular lesions by dietary reserpine
28. Effect of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits in vivo
29. Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits
30. Purification of low density lipoprotein receptor from liver and its quantification by anti-receptor monoclonal antibodies
31. Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody
32. Measurements of the absolute number of functioning low-density lipoprotein receptor in vivo using monoclonal antibody
33. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
34. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo
35. Measurements in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta: Predominance on intimal degradation
36. Influx and cellular degradation of low density lipoproteins in rabbit aorta determined in an in vitro perfusion system
37. 125Ityramine cellobiose-labeled low density lipoprotein is greater in atherosclerosis susceptible region of white Carneau pigeon aorta and further enhanced once atherosclerosis develop
38. Sequentital microenzymatic assay of cholesterol, triglycerides, and phospholipids in a single aliquot
39. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
40. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
41. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17α-ethinyl estradiol
42. Altered compliance and residual strain precede angiographically detected early atherosclerosis in low-density lipoprotein receptor deficiency
43. The influence of protein and carbohydrate type on serum and liver lipids and lipoprotein cholesterol in rabbits
44. Antihypercholesterolemic activity of β-sitostanol in rabbits
45. Studies of the initial anticoagulant response in tissue-thromboplastin induced intravascular coagulation
46. Effects of reserpine treatment on arrhythmogenesis during reperfusion in the isolated rat heart
47. Retarding effect of lowered heart rate on coronary atherosclerosis
48. Heart rate and cardiovascular mortality: The Framingham study
49. Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leucocytes
50. Epinephrine decreases low density lipoprotein processing and lipid synthesis in cultured human fibroblasts
51. Plasma high density lipoprotein concentration and development of ischaemic heart disease
52. Identification and assessment of cardiac risk: An overview
53. Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men
54. Changes in blood coagulation and fibrinolysis in rats fed atherogenic diets
55. Influence of longterm, low dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension